ArticlePloS one2026
Spectral characteristics of light and their association with myopia progression in children: A systematic review protocol.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The rising prevalence of myopia, particularly among children, has emerged as a major global public health concern. Emerging evidence indicates that the spectral composition of light may play a critical role in regulating ocular growth and influencing the onset and progression of myopia. However, the available evidence is characterized by substantial heterogeneity in study design, exposure assessment, and myopia-related outcome measures, making it difficult to draw consistent conclusions. This systematic review aims to identify and evaluate specific spectral profiles of light associated with measurable reductions in myopia progression. To achieve a comprehensive synthesis, evidence from observational human studies and clinical trials will be systematically reviewed. A systematic literature search will be conducted across major databases including PubMed, Scopus, Web of Science, Embase, Cumulative Index to Nursing and Allied Health Literature (CINAHL), PsycINFO, Cochrane Register of Controlled Trials (CENTRAL), and Google Scholar, without restrictions on language or publication period using defined keywords. Eligible studies will include those examining the relationship between light wavelength, spectral irradiance, temporal dynamics, and myopia progression. Two reviewers will independently perform study selection, data extraction, and quality appraisal using validated tools appropriate to each design, including the Cochrane Risk of Bias 2 (RoB 2), Risk of Bias in Non-Randomized Studies of Interventions (ROBINS-I), Joanna Briggs Institute (JBI) checklists, and the National Heart, Lung, and Blood Institute (NHLBI) quality assessment tools. Data will be synthesized narratively, and a meta-analysis conducted where study comparability permits. Taken together, this systematic review protocol outlines a rigorous and transparent approach to consolidate current evidence on the influence of light spectra on myopia development, identify methodological limitations, and outline research priorities to guide future clinical trials, and public health strategies aimed at mitigating childhood myopia progression globally. This review is registered in PROSPERO [CRD420251171027].
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.